US Patent 7723336 Fused heterocyclic compounds useful as kinase modulators

Patent 7723336 was granted and assigned to Bristol-Myers Squibb on May, 2010 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

May 25, 2010

Patent Application Number

11689132

Date Filed

March 21, 2007

Patent Citations Received

Patent Primary Examiner

Patent abstract

Compounds having the formula (I), and enantiomers, and diastereomers, pharmaceutically-acceptable salts, thereof,

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 7723336 Fused heterocyclic compounds useful as kinase modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.